Beijing, Beijing, China Reignwood Group is the famous Corporate Investor, which was founded in 1984. The venture was found in Asia in China. The main department of described Corporate Investor is located in the Beijing.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Reignwood Group, startups are often financed by Carrie Cox. The meaningful sponsors for the fund in investment in the same round are Pacific Eagle Asset Management, Gavril Yushvaev, Brady Dougan. In the next rounds fund is usually obtained by California Institute for Regenerative Medicine.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Humacyte. Among the most successful fund investment fields, there are Biotechnology, Medical Device.
The top activity for fund was in 2015. The common things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 deals per year.
| Fund Name | Location |
| California Narcotic Canine Association | California, Salinas, United States |
| Coffee Ventures | Central, Central Region, Singapore |
| CVA Angels | Richmond, United States, Virginia |
| Liebenthal Ventures | - |
| MK | Japan, Kyoto, Kyoto Prefecture |
| Nehemiah Investments | New Jersey, Princeton, United States |
| ST Engineering Ventures Fund | Central, Central Region, Singapore |
| VisionTech Angels | Indiana, Indianapolis, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Humacyte | $150M | 20 Oct 2015 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Humacyte | $150M | 20 Oct 2015 | North Carolina, United States |
